Abstract Background Cardiovascular diseases (CVDs) culminating into heart failure (HF) are
major causes of death in men and women. Prevalence and manifestation, however, differ …

Pulmonary arterial hypertension (PAH) is a debilitating and progressive disease that
predominantly develops in women. Over the past 15 years, cumulating evidence has …

Background Women are at greater risk of developing pulmonary arterial hypertension, with
estrogen and its downstream metabolites playing a potential role in the pathogenesis of the …

Rationale: CYPs (cytochrome p450) are critically involved in the metabolism of xenobiotics
and toxins. Given that pulmonary hypertension is strongly associated with environmental …

Pulmonary arterial hypertension (PAH) is more prevalent in females. Paradoxically, female
patients have better right ventricular (RV) function and higher survival rates than males …

Pulmonary arterial hypertension (PAH) is one of the diseases with a well-established gender
dimorphism. The prevalence of PAH is increased in females with a ratio of 4: 1, while poor …

Estradiol may antagonize the adverse cardiovascular effects of angiotensin II (Ang II). We
investigated the effects of 2-methoxyestradiol (2-ME), a nonestrogenic estradiol metabolite …

В работе представлен обзор литературных данных, относящихся к влиянию кальций-
регулирующей гормональной системы организма (паратиреоидный гормон …

Heart failure (HF) is one of the major health threats of western societies. Women are more
likely to survive than men and HF in women frequently occurs at an older age and with less …

Abstract Background: Cardiovascular diseases (CVDs) culminating into heart failure (HF)
are major causes of death in men and women. Prevalence and manifestation, however …